Dive Brief:

Elevance has named a longtime drug distributor executive to its board of directors as the health insurer focuses on building its pharmacy services.

Steve Collis, the executive chair of Cencora’s board and the company’s former CEO, will join Elevance’s board effective Aug. 1, the health insurer announced Monday.

Collis will also serve on the board’s audit and finance committees, Elevance said. His term will run through 2027.

Dive Insight:

Collis joined Cencora, then called Amerisource Bergen, three decades ago before climbing the corporate ladder through a variety of leadership roles. He was named CEO in 2011, and held the role for 13 years before retiring in 2024, though he stayed on as chairman of the drug distributor’s board.

“Steve brings a distinguished record of le

See Full Page